PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.59%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-25.49%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-26.18%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-29.30%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-29.11%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-28.57%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.43%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.42%
Diluted share change of 0.42% while ADI is zero. Bruce Berkowitz might see a minor difference that could widen over time.
0.43%
Dividend growth 1.25-1.5x ADI's 0.34%. Bruce Berkowitz would see if management’s capital return strategy is more aggressive yet sustainable.
-58.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-65.34%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
103.42%
10Y revenue/share CAGR above 1.5x ADI's 12.57%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
38.18%
5Y revenue/share CAGR at 75-90% of ADI's 43.48%. Bill Ackman would encourage strategies to match competitor’s pace.
17.88%
3Y revenue/share CAGR similar to ADI's 18.64%. Walter Schloss would assume both companies experience comparable short-term cycles.
557.38%
10Y OCF/share CAGR above 1.5x ADI's 2.11%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
25.82%
5Y OCF/share CAGR at 50-75% of ADI's 51.34%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-8.46%
Negative 3Y OCF/share CAGR while ADI stands at 22.14%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
339.00%
Net income/share CAGR above 1.5x ADI's 39.22% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
54.62%
Below 50% of ADI's 125.44%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
14.40%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
23.29%
Below 50% of ADI's 58.09%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
27.79%
5Y equity/share CAGR above 1.5x ADI's 10.98%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
21.98%
3Y equity/share CAGR at 50-75% of ADI's 43.79%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
526.91%
Dividend/share CAGR of 526.91% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
332.92%
5Y dividend/share CAGR above 1.5x ADI's 82.63%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
30.81%
3Y dividend/share CAGR 1.25-1.5x ADI's 22.21%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
3.29%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.39%
Inventory growth well above ADI's 1.98%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.68%
Negative asset growth while ADI invests at 6.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.75%
Under 50% of ADI's 5.15%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
7.65%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
1.54%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.